Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Capital Expenditures (2016)

Historic Capital Expenditures for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q4 2016 value amounting to -$3000.0.

  • Eledon Pharmaceuticals' Capital Expenditures fell 10138.89% to -$3000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $9000.0, marking a year-over-year decrease of 9840.71%. This contributed to the annual value of $9000.0 for FY2016, which is 9840.71% down from last year.
  • According to the latest figures from Q4 2016, Eledon Pharmaceuticals' Capital Expenditures is -$3000.0, which was down 10138.89% from $2000.0 recorded in Q3 2016.
  • In the past 5 years, Eledon Pharmaceuticals' Capital Expenditures registered a high of $216000.0 during Q4 2015, and its lowest value of -$7000.0 during Q2 2016.
  • Its 4-year average for Capital Expenditures is $50250.0, with a median of $9500.0 in 2014.
  • Its Capital Expenditures has fluctuated over the past 5 years, first skyrocketed by 235000.0% in 2015, then plummeted by 10476.19% in 2016.
  • Quarter analysis of 4 years shows Eledon Pharmaceuticals' Capital Expenditures stood at $4000.0 in 2013, then soared by 75.0% to $7000.0 in 2014, then skyrocketed by 2985.71% to $216000.0 in 2015, then tumbled by 101.39% to -$3000.0 in 2016.
  • Its Capital Expenditures was -$3000.0 in Q4 2016, compared to $2000.0 in Q3 2016 and -$7000.0 in Q2 2016.